hinge health inc - HNGE

HNGE

Close Chg Chg %
48.75 -0.60 -1.23%

Closed Market

48.15

-0.60 (1.23%)

Volume: 267.55K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: hinge health inc - HNGE

HNGE Key Data

Open

$48.96

Day Range

48.09 - 49.15

52 Week Range

N/A - N/A

Market Cap

$3.84B

Shares Outstanding

78.72M

Public Float

20.24M

Beta

4.72

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$5.49

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.29M

 

HNGE Performance

1 Week
 
2.01%
 
1 Month
 
-1.45%
 
3 Months
 
-0.54%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

HNGE Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15
Full Ratings ➔

About hinge health inc - HNGE

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The firm has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

HNGE At a Glance

Hinge Health, Inc.
455 Market Street
San Francisco, California 94105
Phone 1-415-726-2206 Revenue 390.40M
Industry Packaged Software Net Income -11,933,000.00
Sector Technology Services 2024 Sales Growth 33.367%
Fiscal Year-end 12 / 2025 Employees N/A
View SEC Filings

HNGE Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

HNGE Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 9.187
Total Asset Turnover 0.60

HNGE Liquidity

Current Ratio 2.266
Quick Ratio 2.166
Cash Ratio 1.879

HNGE Profitability

Gross Margin 76.995
Operating Margin -6.257
Pretax Margin -2.883
Net Margin -3.057
Return on Assets -1.834
Return on Equity -2.828
Return on Total Capital -2.79
Return on Invested Capital -2.768

HNGE Capital Structure

Total Debt to Total Equity 2.657
Total Debt to Total Capital 2.588
Total Debt to Total Assets 1.639
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 1.697
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hinge Health Inc - HNGE

Collapse All in section
All values USD millions. 2023 2024 5-year trend
Sales/Revenue
- - 292.73M 390.40M
-
Sales Growth
- - - +33.37%
-
Cost of Goods Sold (COGS) incl D&A
- - 98.55M 89.81M
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 5.63M 5.95M
-
Depreciation
- - 5.23M 5.55M
-
Amortization of Intangibles
- - 400.00K 400.00K
-
COGS Growth
- - - -8.87%
-
Gross Income
- - 194.18M 300.59M
-
Gross Income Growth
- - - +54.80%
-
Gross Profit Margin
- - +66.33% +77.00%
-
2023 2024 5-year trend
SG&A Expense
- - 324.69M 325.02M
-
Research & Development
- - 110.06M 97.49M
-
Other SG&A
- - 214.63M 227.53M
-
SGA Growth
- - - +0.10%
-
Other Operating Expense
- - - -
-
Unusual Expense
- - - 7.48M
-
EBIT after Unusual Expense
- - (130.51M) (31.91M)
-
Non Operating Income/Expense
- - 21.97M 20.65M
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
- - (108.55M) (11.26M)
-
Pretax Income Growth
- - - +89.63%
-
Pretax Margin
- - -37.08% -2.88%
-
Income Tax
- - (405.00K) 677.00K
-
Income Tax - Current - Domestic
- - - 624.00K
-
Income Tax - Current - Foreign
- - 68.00K 638.00K
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - (473.00K) (585.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
- - (108.14M) (11.93M)
-
Minority Interest Expense
- - - -
-
Net Income
- - (108.14M) (11.93M)
-
Net Income Growth
- - - +88.97%
-
Net Margin Growth
- - -36.94% -3.06%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- - (108.14M) (11.93M)
-
Preferred Dividends
- - - -
-
Net Income Available to Common
- - (108.14M) (11.93M)
-
EPS (Basic)
- - -1.3861 -0.153
-
EPS (Basic) Growth
- - - +88.96%
-
Basic Shares Outstanding
- - 78.02M 78.02M
-
EPS (Diluted)
- - -1.3861 -0.153
-
EPS (Diluted) Growth
- - - +88.96%
-
Diluted Shares Outstanding
- - 78.02M 78.02M
-
EBITDA
- - (124.89M) (18.48M)
-
EBITDA Growth
- - - +85.20%
-
EBITDA Margin
- - -42.66% -4.73%
-

Snapshot

Average Recommendation BUY Average Target Price 64.286
Number of Ratings 15 Current Quarters Estimate 0.412
FY Report Date 12 / 2025 Current Year's Estimate 1.386
Last Quarter’s Earnings 0.422 Median PE on CY Estimate N/A
Year Ago Earnings N/A Next Fiscal Year Estimate 1.592
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 14 13 14
Mean Estimate 0.41 0.29 1.39 1.59
High Estimates 0.44 0.41 1.68 1.94
Low Estimate 0.40 0.11 1.22 1.41
Coefficient of Variance 2.71 25.41 10.20 8.37

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 12
OVERWEIGHT 2 2 2
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Hinge Health Inc in the News